Bone Index Ltd. Announces Medicare Reimbursement Coverage for Bindex Osteoporosis Measurement
Bone Index Ltd., a medical device company with a game changer point-of-care technology (Bindex®) in osteoporosis diagnostics, announces that U.S. Centers for Medicare & Medicaid Services (CMS) has approved coverage for Bindex® measurement in the Ambulatory Surgical Center (ASC) setting, when provided integral to a surgical procedure on ASC list*. In addition, the coverage includes the outpatient hospital settings*. “This significant reimbursement coverage is a remarkable milestone for Bindex measurement. In addition, this is a great example how CMS wants to improve the healthcare in US.